HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wlodzimierz Buczko Selected Research

Carotid Artery Thrombosis

6/2007A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wlodzimierz Buczko Research Topics

Disease

10Thrombosis (Thrombus)
04/2015 - 11/2002
5Venous Thrombosis (Deep-Vein Thrombosis)
01/2013 - 11/2002
3Chronic Kidney Failure (Chronic Renal Failure)
07/2012 - 01/2003
3Uremia
04/2003 - 08/2002
2Hemorrhage
07/2012 - 06/2007
2Anemia
07/2012 - 04/2003
2Renal Insufficiency (Renal Failure)
04/2003 - 01/2003
2Chronic Renal Insufficiency
01/2003 - 08/2002
1Cardiovascular Diseases (Cardiovascular Disease)
07/2012
1Asthma (Bronchial Asthma)
01/2008
1Carotid Artery Thrombosis
06/2007
1Renovascular Hypertension (Goldblatt Syndrome)
04/2005
1Hypertension (High Blood Pressure)
04/2005
1Pulmonary Embolism
12/2003
1Paralysis (Palsy)
12/2003
1Hypoxia (Hypoxemia)
04/2003
1Nervous System Diseases (Neurological Disorders)
01/2003
1Fibrosis (Cirrhosis)
01/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2003
1Airway Remodeling
01/2003
1Brain Diseases (Brain Disorder)
08/2002

Drug/Important Bio-Agent (IBA)

4KynurenineIBA
01/2008 - 08/2002
33-hydroxykynurenineIBA
01/2003 - 08/2002
3Tryptophan (L-Tryptophan)FDA Link
01/2003 - 08/2002
2aliskirenFDA Link
04/2015 - 01/2013
2Hemostatics (Antihemorrhagics)IBA
04/2015 - 09/2012
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2013 - 12/2003
2FibrinIBA
09/2012 - 01/2003
2Losartan (Cozaar)FDA LinkGeneric
06/2005 - 12/2003
2CollagenIBA
04/2005 - 12/2003
2Quinolinic AcidIBA
04/2003 - 01/2003
1Pyridinium CompoundsIBA
04/2014
1trigonellineIBA
04/2014
1CoffeeFDA Link
04/2014
1Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2013
1sodium boranocarbonateIBA
09/2012
1Carbon MonoxideIBA
09/2012
1Plasminogen Activators (Plasminogen Activator)IBA
09/2012
1PhosphatidylserinesIBA
09/2012
1Green Fluorescent ProteinsIBA
09/2012
1Dextrans (Dextran)FDA Link
07/2012
1Protamines (Protamine Sulfate)FDA Link
07/2012
1PolymersIBA
07/2012
1AnticoagulantsIBA
07/2012
1Heparin (Liquaemin)FDA LinkGeneric
07/2012
1OvalbuminIBA
01/2008
1Immunoglobulin E (IgE)IBA
01/2008
1Recombinant ProteinsIBA
06/2007
1SAK-RGD-K2-HirIBA
06/2007
1Proteins (Proteins, Gene)FDA Link
06/2007
1Angiotensin IIIBA
06/2005
1Cathepsin AIBA
04/2005
1ebelactone BIBA
04/2005
1Proteasome InhibitorsIBA
07/2004
1leucinalIBA
07/2004
1Epinephrine (Adrenaline)FDA LinkGeneric
12/2003
1losartan carboxylic acidIBA
12/2003
1Valsartan (Vals)FDA Link
12/2003
1ErythropoietinFDA Link
04/2003
1CobaltIBA
04/2003
1FibrinolysinFDA Link
01/2003
1EnzymesIBA
01/2003
1Plasminogen Activator Inhibitor 1IBA
01/2003
1Matrix Metalloproteinases (MMPs)IBA
01/2003
1anthranilic acid (anthranilate)IBA
01/2003

Therapy/Procedure

2Surgical Instruments (Clip)
01/2013 - 07/2004
1Oral Administration
01/2013
1Lasers (Laser)
09/2012
1Ligation
06/2005
1Intravenous Injections
12/2003
1Intravenous Infusions
11/2002